• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲脑膜炎带脑膜炎球菌性脑膜炎的发病率、带菌情况及病例与带菌者比例:一项系统评价与荟萃分析

Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.

作者信息

Koutangni Thibaut, Boubacar Maïnassara Halima, Mueller Judith E

机构信息

EHESP French School of Public Health, Sorbonne Paris Cité, Rennes, France; Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.

Centre de Recherche Médicale et Sanitaire (CERMES), Niamey, Niger.

出版信息

PLoS One. 2015 Feb 6;10(2):e0116725. doi: 10.1371/journal.pone.0116725. eCollection 2015.

DOI:10.1371/journal.pone.0116725
PMID:25658307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4319942/
Abstract

BACKGROUND

To facilitate the interpretation of meningococcal meningitis epidemiology in the "African meningitis belt", we aimed at obtaining serogroup-specific pooled estimates of incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt and describe their variations across the endemic, hyperendemic and epidemic context.

METHODS

We conducted a systematic review and meta-analysis of studies reporting serogroup-specific meningococcal meningitis monthly incidence and carriage in the same population and time period. Epidemiological contexts were defined as endemic (wet season, no epidemic), hyperendemic (dry season, no epidemic), and epidemic (dry season, epidemic).

FINDINGS: Eight studies reporting a total of eighty pairs of serogroup-specific meningococcal meningitis incidence and carriage estimates were included in this review. For serogroup A, changes associated with the transition from endemic to hyperendemic incidence and from hyperendemic to epidemic incidence were 15-fold and 120-fold respectively. Changes in carriage prevalence associated with both transitions were 1-fold and 30-fold respectively. 
For serogroup W and X, the transition from endemic to hyperendemic incidence involved a 4-fold and 1•1-fold increase respectively. Increases in carriage prevalence for the later transition were 7-fold and 1•7-fold respectively. No data were available for the hyperendemic-epidemic transition for these serogroups. Our findings suggested that the regular seasonal variation in serogroup A meningococcal meningitis incidence between the rainy and the dry season could be mainly driven by seasonal change in the ratio of clinical cases to subclinical infections. In contrast appearance of epidemic incidences is related to a substantial increase in transmission and colonisation and to lesser extent with changes in the case-carrier ratio.

CONCLUSION

Seasonal change in the rate of progression to disease given carriage together with variations in frequency of carriage transmission should be considered in models attempting to capture the epidemiology of meningococcal meningitis and mainly to predict meningitis epidemics in the African meningitis belt.

摘要

背景

为便于解读“非洲脑膜炎带”的脑膜炎球菌性脑膜炎流行病学情况,我们旨在获取非洲脑膜炎带脑膜炎球菌性脑膜炎血清群特异性发病率、带菌率及病例 - 带菌者比例的汇总估计值,并描述其在地方性、高度地方性和流行性环境中的变化情况。

方法

我们对在同一人群和时间段内报告血清群特异性脑膜炎球菌性脑膜炎月发病率和带菌率的研究进行了系统评价和荟萃分析。流行病学环境被定义为地方性(雨季,无疫情)、高度地方性(旱季,无疫情)和流行性(旱季,有疫情)。

结果

本综述纳入了八项研究,共报告了八十对血清群特异性脑膜炎球菌性脑膜炎发病率和带菌率估计值。对于A群,从地方性发病率转变为高度地方性发病率以及从高度地方性发病率转变为流行性发病率时,发病率的变化分别为15倍和120倍。与这两种转变相关的带菌率变化分别为1倍和30倍。对于W群和X群,从地方性发病率转变为高度地方性发病率时,发病率分别增加了4倍和1.1倍。后一种转变时带菌率的增加分别为7倍和1.7倍。这些血清群在高度地方性 - 流行性转变方面没有可用数据。我们的研究结果表明,A群脑膜炎球菌性脑膜炎发病率在雨季和旱季之间的常规季节性变化可能主要由临床病例与亚临床感染比例的季节性变化驱动。相比之下,流行性发病率的出现与传播和定植的大幅增加有关,在较小程度上与病例 - 带菌者比例的变化有关。

结论

在试图描述脑膜炎球菌性脑膜炎流行病学情况,特别是预测非洲脑膜炎带脑膜炎疫情的模型中,应考虑带菌情况下疾病进展速率的季节性变化以及带菌传播频率的变化。

相似文献

1
Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.非洲脑膜炎带脑膜炎球菌性脑膜炎的发病率、带菌情况及病例与带菌者比例:一项系统评价与荟萃分析
PLoS One. 2015 Feb 6;10(2):e0116725. doi: 10.1371/journal.pone.0116725. eCollection 2015.
2
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.在印度成年人中,五价脑膜炎球菌结合疫苗与四价脑膜炎球菌结合疫苗的安全性和免疫原性:一项观察者盲法、随机、活性对照、2/3期研究。
Lancet Infect Dis. 2025 Apr;25(4):399-410. doi: 10.1016/S1473-3099(24)00576-0. Epub 2024 Nov 6.
3
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
4
Meningococcal carriage by age: a systematic review and meta-analysis.年龄与脑膜炎奈瑟菌带菌率:系统评价与荟萃分析。
Lancet Infect Dis. 2010 Dec;10(12):853-61. doi: 10.1016/S1473-3099(10)70251-6. Epub 2010 Nov 11.
5
Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region.系统评价东地中海和北非地区侵袭性脑膜炎奈瑟菌病的流行病学。
BMC Infect Dis. 2021 Oct 22;21(1):1088. doi: 10.1186/s12879-021-06781-6.
6
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.脑膜炎球菌 A、C、W、19A、Y 五价结合疫苗在马里和冈比亚 2 至 29 岁人群中的应用。
N Engl J Med. 2023 May 25;388(21):1942-1955. doi: 10.1056/NEJMoa2214924.
7
Burden of infections in China: a systematic review and meta-analysis.中国感染负担:一项系统评价与荟萃分析
J Glob Health. 2016 Dec;6(2):020409. doi: 10.7189/jogh.06.020409.
8
Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.用于预防A群脑膜炎球菌性脑膜炎的多糖疫苗。
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD001093. doi: 10.1002/14651858.CD001093.pub2.
9
Meningococcal carriage in high-risk settings: A systematic review.高危环境中的脑膜炎奈瑟菌带菌情况:系统综述。
Int J Infect Dis. 2018 Aug;73:109-117. doi: 10.1016/j.ijid.2018.05.022. Epub 2018 Jul 8.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Fatal case of meningococcal meningitis in a child from rural Bhutan: A case report.不丹农村一名儿童患致命性脑膜炎球菌性脑膜炎:病例报告。
Clin Case Rep. 2024 Aug 28;12(9):e9396. doi: 10.1002/ccr3.9396. eCollection 2024 Sep.
2
Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review.全球 1973-2018 年侵袭性脑膜炎奈瑟菌病疫情的公共卫生管理:系统评价。
BMC Public Health. 2024 Aug 20;24(1):2254. doi: 10.1186/s12889-024-19740-y.
3
Impact of Meningococcal ACWY Vaccination Program during 2017-18 Epidemic, Western Australia, Australia.

本文引用的文献

1
Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.2008 年布基纳法索 A 群脑膜炎奈瑟菌杀菌、特异性 IgG 抗体的血清流行率与年龄相关及脑膜炎发病情况
PLoS One. 2013;8(2):e55486. doi: 10.1371/journal.pone.0055486. Epub 2013 Feb 14.
2
Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults.非洲脑膜炎带中的肺炎球菌:儿童和成人的脑膜炎发病率和带菌流行率。
PLoS One. 2012;7(12):e52464. doi: 10.1371/journal.pone.0052464. Epub 2012 Dec 20.
3
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
2017-18 年流行期间澳大利亚西澳大利亚的脑膜炎奈瑟菌 A、C、W、Y 疫苗接种计划的影响。
Emerg Infect Dis. 2024 Feb;30(2):270-278. doi: 10.3201/eid3002.230144.
4
An Overview of Meningococcal Disease's Recent Diagnostic and Treatment Model.脑膜炎球菌病最新诊断与治疗模式概述
Cureus. 2023 Nov 8;15(11):e48509. doi: 10.7759/cureus.48509. eCollection 2023 Nov.
5
Using Clinical Vignettes to Understand the Complexity of Diagnosing Type 1 Diabetes in Sub-Saharan Africa.利用临床案例了解撒哈拉以南非洲地区1型糖尿病诊断的复杂性。
Res Rep Trop Med. 2023 Nov 13;14:111-120. doi: 10.2147/RRTM.S397127. eCollection 2023.
6
The meningitis outbreak returns to Niger: Concern, efforts, challenges, and recommendations.脑膜炎疫情在尼日尔卷土重来:关注、努力、挑战和建议。
Immun Inflamm Dis. 2023 Jul;11(7):e953. doi: 10.1002/iid3.953.
7
Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns.布基纳法索在大规模脑膜炎疫苗接种运动 5 年后,人们对细菌性脑膜炎预防的知识、信念和做法。
PLoS One. 2021 Jul 14;16(7):e0253263. doi: 10.1371/journal.pone.0253263. eCollection 2021.
8
Design, synthesis, and structural elucidation of novel NmeNANAS inhibitors for the treatment of meningococcal infection.设计、合成及新型 NmeNANAS 抑制剂的结构解析用于脑膜炎奈瑟菌感染的治疗。
PLoS One. 2019 Oct 16;14(10):e0223413. doi: 10.1371/journal.pone.0223413. eCollection 2019.
9
Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.非洲脑膜炎带中年龄相关的脑膜炎奈瑟菌携带情况:系统评价和荟萃分析。
Epidemiol Infect. 2019 Jan;147:e228. doi: 10.1017/S0950268819001134.
10
Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.近年来世界范围内脑膜炎奈瑟菌 W 群的流行病学变化、当前的疫苗接种政策选择和未来可能的策略。
Hum Vaccin Immunother. 2019;15(2):470-480. doi: 10.1080/21645515.2018.1532248. Epub 2018 Oct 26.
脑膜炎球菌病研究重点及 A 群脑膜炎球菌疫苗接种对非洲脑膜炎地带的影响。
Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.
4
Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.定义和描述布基纳法索局部性脑膜炎流行:一项纵向回顾性研究。
BMC Infect Dis. 2012 Jan 5;12:2. doi: 10.1186/1471-2334-12-2.
5
Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.布基纳法索局限性流脑脑膜炎的研究:发病率、带菌率和免疫情况。
J Infect Dis. 2011 Dec 1;204(11):1787-95. doi: 10.1093/infdis/jir623. Epub 2011 Oct 12.
6
Modelling meningococcal meningitis in the African meningitis belt.在非洲脑膜炎带中建立脑膜炎奈瑟菌脑膜炎模型。
Epidemiol Infect. 2012 May;140(5):897-905. doi: 10.1017/S0950268811001385. Epub 2011 Jul 25.
7
Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso.出现了流行性奈瑟氏脑膜炎奈瑟菌 X 群脑膜炎在多哥和布基纳法索。
PLoS One. 2011;6(5):e19513. doi: 10.1371/journal.pone.0019513. Epub 2011 May 20.
8
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.在引进A群脑膜炎球菌结合疫苗之前布基纳法索的脑膜炎球菌带菌情况基线。
Clin Vaccine Immunol. 2011 Mar;18(3):435-43. doi: 10.1128/CVI.00479-10. Epub 2011 Jan 12.
9
Olfactory nerve--a novel invasion route of Neisseria meningitidis to reach the meninges.嗅神经——脑膜炎奈瑟菌到达脑膜的新入侵途径。
PLoS One. 2010 Nov 18;5(11):e14034. doi: 10.1371/journal.pone.0014034.
10
Meningococcal disease and climate.脑膜炎球菌病与气候
Glob Health Action. 2009 Nov 11;2. doi: 10.3402/gha.v2i0.2061.